Clinical Laboratory in Washington

Kamiya Biomedical Company manufactures clinical diagnostics assay reagents, research ELISAs, antibodies, and biochemicals for laboratory and preclinical use. Primary product lines include immunoassay and immunoturbidimetric reagents adapted to most major automated chemistry analyzers (Roche Cobas, Hitachi, Beckman, Olympus, Siemens, Abbott, and others), spanning rheumatoid factor, C-reactive protein, D-dimer, ferritin, immunoglobulins, β-2 microglobulin, microtransferrin, vitamin C, apolipoprotein assays, H. pylori testing, and KL-6 measurement. The company also manufactures thousands of ELISA kits for human research and preclinical/animal testing across 20+ species (mouse, rat, dog, cat, primate, bovine, porcine, avian, and others). Secondary offerings include 1,300+ monoclonal and polyclonal antibodies; 200+ biochemicals (recombinants, substrates, inhibitors, polymerases); and laboratory testing services for lipid and vitamin C analysis. Several assays carry regulatory status for clinical diagnostics (ISO 13485, CE Mark), while others are designated research-use-only in the US. The company also produces animal assay reagents for veterinary diagnostics (dog CRP, cat serum amyloid A) and has developed COVID-19 response reagents. Founded in 1983, Kamiya serves clinical laboratories, research institutions, and preclinical/pharmaceutical development markets. Manufacturing capabilities include custom antibody production, ELISA kit formulation, and reagent adaptation to third-party chemistry analyzer platforms.

US BioTek Laboratories is a functional and integrative medicine diagnostic laboratory specializing in precision testing for naturopathic doctors, functional medicine practitioners, and integrative healthcare providers. The company operates a CLIA-certified and CAP-accredited laboratory offering comprehensive testing panels across six primary areas: Food Sensitivity Testing (IgG antibody assessment), GI Microbiome Testing (bacterial composition and metabolite analysis), Environmental Toxin Testing (mycotoxins, glyphosate, and pollutant detection), Food Allergy Testing (IgE antibody profiling), Organic Acids Testing (metabolic markers including NAD/NADH), and Hormone Testing (steroid and other hormonal markers). Their VeriTek™ quality assurance methodology emphasizes automated systems, superior assay preparation, duplicate testing protocols, and external accreditation to ensure reproducible results. The company provides collection kits with prepaid return shipping, rapid turnaround times, and results delivery via a provider portal. US BioTek serves the functional medicine and naturopathic medicine markets and recently completed a merger with NutriPATH Pathology to expand service offerings. The laboratory is positioned for practitioners seeking specialty diagnostic tools to guide precision treatment recommendations and is particularly utilized in anti-aging medicine, gastrointestinal health assessment, hormone optimization, and environmental toxicology.

Molecular Testing Labs is a CLIA-certified and CAP-accredited clinical laboratory operating facilities in Vancouver, WA (CLIA# 50D2050397, CAP# 8690528) and Irving, TX (CLIA# 45D2278063, CAP# 9607237). The company processes hundreds of thousands of diagnostic tests monthly on both clinically and non-clinically collected samples. Their scientific team includes world-class clinicians, PhDs, research scientists, and diagnostic technicians focused on advancing diagnostic accessibility and equity in healthcare. MLT offers end-to-end diagnostic services across multiple therapeutic and clinical areas. Core service lines include comprehensive drug testing and toxicology screening with confirmation methodologies, GLP-1 weight management adherence testing using advanced diagnostics to monitor treatment efficacy, and population health testing solutions designed to close care gaps and improve health outcomes. They provide tailored solutions for diverse markets including clinics, digital health companies, public health departments, research universities, and telehealth platforms. The company emphasizes quality systems, compliance leadership, and patient-centered diagnostics. Their operations include sample logistics, specimen handling, and results reporting integrated with clinical workflows. MTL maintains rigorous quality measures, continuous compliance training, and auditing protocols. The organization is committed to making diagnostic care accessible while maintaining stringent regulatory adherence and ethical standards across all testing operations.

Immunexpress develops rapid diagnostic technology for sepsis detection based on immune response biomarker analysis. The company's flagship product, SeptiCyte® RAPID, is a fully automated cartridge compatible with the Biocartis Idylla™ platform that quantifies and analyzes gene expression from whole blood samples to diagnose sepsis in suspected patients within one hour—compared to traditional testing methods that require 24–48 hours and produce actionable results in only 20% of cases. SeptiCyte® RAPID delivers clinically actionable results for 100% of tested patients. The technology addresses a critical clinical need: sepsis remains the leading cause of death in hospitals globally (11 million deaths annually among 49 million cases), yet early detection is hampered by inadequate diagnostic tools. By enabling rapid diagnosis, Immunexpress's solution aims to reduce mortality rates, shorten hospital stays, and lower healthcare costs. The company targets acute care hospitals and clinicians managing suspected sepsis cases across intensive care and emergency departments. Manufacturing and delivery are achieved through partnership with Biocartis, leveraging their Idylla™ automated molecular analysis platform.

Kent Laboratories, Inc. is an FDA-registered manufacturer of diagnostic reagents and immunological products for clinical laboratories and research institutions, operating since 1974. The company specializes in radial immunodiffusion (RID) kits and plates for protein quantification, fluorescein-conjugated antisera (FITC conjugates) for immunofluorescence microscopy and direct immunofluorescence (DIF) testing, and related immunological reagents including immunoglobulins, complement components, acute phase proteins, and control serum. Products are primarily used in clinical pathology, dermatopathology (skin biopsy analysis), and research settings. Kent Laboratories maintains an 80-acre farm operation and sources conjugates in-house. The company is FDA-registered, follows current Good Manufacturing Practices (GMP), holds USDA and NIH affiliations, and maintains an in vitro diagnostic (IVD) designation. All products undergo rigorous quality control and are shipped via second-day air from their Bellingham, Washington facility. The product line serves clinical laboratories performing immunological testing, research institutions, and specialized diagnostic centers requiring high-accuracy serological and immunofluorescence reagents.

Kevadx is a U.S.-based diagnostics manufacturer specializing in rapid point-of-care diagnostic test kits. The company develops and manufactures solutions across infectious diseases, fertility testing, and drug screening applications. Products are designed for quick, accurate detection in clinical, occupational health, and public health settings. The company operates state-of-the-art manufacturing facilities with integrated quality control systems to ensure regulatory compliance and reliability. Distribution occurs through established partners. Product lines emphasize user-friendly designs and seamless integration into healthcare facilities and laboratories. No specific regulatory certifications (FDA 510(k), ISO 13485, CE marking) are mentioned on the website.

Blood Bank Computer Systems, Inc. (BBCS) is an FDA-cleared software company specializing in biologics management solutions for blood banks, plasma donation centers, cell therapy programs, and research institutions. Since 1981, BBCS has pioneered Blood Bank Exemplary Computer Systems (BECS), introducing the first Blood Bank Control System in 1987. The company's flagship ForLife Biologics Platform® is a secure, cloud-based, modular solution built on Amazon Web Services that manages the complete donor-to-patient lifecycle, including donor management, inventory tracking, patient records, billing, and regulatory compliance. ForLife integrates digital donor engagement tools, ISBT labeling for cellular therapy, and comprehensive data conversion capabilities. BBCS serves blood collection centers, hospitals, transfusion centers, plasma donation facilities, cell therapy startups, and university/government research programs. The platform supports 3,500+ users managing 28+ million donations with 16+ years average client retention. Beyond software, BBCS provides technical support, biologics consulting, audit support, data conversion services, customized training, and 24/7 knowledge base access. Implementation includes discovery, development, onboarding, and ongoing support with flexible service level agreements tailored to organizational needs.

STEMCELL Technologies is a life science research company that provides innovative reagents, tools, and services for cell isolation, culture, and assay applications. The company serves academic, clinical, and industrial research laboratories globally with product portfolios spanning immunology, organoid research, hematopoietic cell research, pluripotent stem cell research, cell therapy, and neuroscience research. Their offerings include specialized cell culture media, isolation reagents, and assay tools designed for specific tissue and cell types. The company maintains dedicated scientific support services and offers training programs, including GMP-compliant Human T Cell Expansion courses. STEMCELL also provides diagnostic partnerships and OEM solutions for institutions requiring customized research reagents and protocols. Manufacturing and quality capabilities support laboratory and clinical research applications. The organization operates with a stated mission of "scientists helping scientists" and emphasizes technical expertise and customer collaboration in advancing research outcomes.

Fluke Corporation is a leading manufacturer of compact electronic test tools and software for measuring and condition monitoring. Founded in 1948, the company specializes in precision measurement instruments, thermal imaging systems, electrical testing equipment, and calibration tools. Fluke serves technicians, engineers, electricians, and maintenance managers across manufacturing, healthcare, and service sectors with products including digital multimeters, thermal cameras, power quality analyzers, clamp meters, acoustic imaging systems, and industrial ethernet testers. The company also provides calibration management software (CalStudio) and condition monitoring solutions for predictive maintenance and asset management. Fluke's portfolio extends to renewable energy diagnostics (solar panel testing, I-V curve tracers) and electric vehicle supply equipment (EVSE) testing solutions.

VMRD, Inc. is a veterinary diagnostic manufacturer founded in 1981, headquartered in Pullman, Washington. The company develops and manufactures USDA-licensed ELISA kits, immunofluorescence assay reagents, antibodies, point-of-care diagnostic products, and automated ELISA processing systems. VMRD distributes diagnostic solutions to over 77 countries and serves the veterinary, pharmaceutical, and biologics industries. The company's Testing Services division (formerly ABR) provides comprehensive adventitious agent testing for raw materials, cells, and seeds, including mycoplasma testing, sterility testing, and regulatory viral screening to support compliance and quality assurance requirements. Additional product lines include CWD RT-QuIC reagents for prion detection and nucleic acid extraction kits for molecular applications. With over 50 researchers and technicians, VMRD combines diagnostic innovation with specialized testing services for regulatory and pharmaceutical applications.